OSCR

Omics-based exploration of biomarkers and therapeutic targets in olfactory neuroblastoma.

Overview

Authors: Ning Deng1, Zehao Chen1, Carolina Oi Lam Ung1,2,3, Yunfeng Lai4, Menghuan Song1,2, Hao Hu1,2,3
  1. State Key Laboratory of Mechanism and Quality of Chinese Medicine, University of Macau, Macao, China
  2. Centre for Pharmaceutical Regulatory Sciences, Institute of Chinese Medical Sciences, University of Macau, Macao, China
  3. Department of Public Health and Medicinal Administration, Faculty of Health Sciences, University of Macau, Macao, China
  4. School of Public Health and Management, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong Province China
Institutions: University of Macau (Macao SAR China); Guangzhou University of Chinese Medicine (China)
Journal: Discover oncology, volume 17, issue 1, article 1090
Dates: received 1 February 2026; accepted 21 May 2026; published online 28 May 2026
Type: Review · Language: English
License: CC BY
Identifiers: DOI 10.1007/s12672-026-05299-0 · PMID 42209957 · PMCID PMC13407801 · OpenAlex W7162696727
Open access: gold, a free copy (OpenAlex)
Categories: genetics / omics (modality), human (organism), other condition (population), clinical / translational (subfield)
Keywords: Olfactory neuroblastoma, Omics, Biomarker, Therapeutic target, Target therapy
Topic: Head and Neck Surgical Oncology (Surgery, Medicine), according to OpenAlex
Funding: The Science and Technology Development Fund, Macau SAR (0002/2025/NRP)
Citations: cited by 1 paper (Europe PMC); 48 references in the paper

Abstract

Introduction: Olfactory Neuroblastoma (ONB) is a rare and aggressive malignant tumor with a complex, heterogeneous pathogenesis. Although various omics studies have been conducted for ONB recently, there is still no omics evidence summary for ONB. Therefore, this study systematically reviews and synthesizes evidence across multiple omics layers for identifying biomarkers and therapeutic targets of ONB, aiming to advance the translation of molecular insights into clinical applications, including subtype classification, targeted therapy, and drug development.

Methods: We conducted a systematic review following the PRISMA 2020 guidelines and registered with PROSPERO (ID: CRD420251128889). Five databases were searched up to 31st May 2025 for original studies that applied single- or multi-omics analyses to ONB. Risk of bias was assessed using the JBI Case Series Checklist.

Results: A total of 24 studies were included, covering genomics (11/24), transcriptomics (5/24), proteomics (1/24), and multi-omics integration (7/24). Genomic studies identified recurrent mutations (e.g., TP53, IDH2), chromosomal alterations (e.g., 1p, 3p, 13q), and pathway-level changes (e.g., PI3K/AKT/mTOR, chromatin remodeling). Transcriptomic studies revealed Basal, Neural, and Mesenchymal subtypes, with NEUROD1 and EZH2 serving as key biomarkers. For proteomics, one immunohistochemistry-focused study reports markers such as Trk proteins and GRP78. Multi-omics studies integrated subtyping, tumor-origin hypotheses, and immune landscape characterization, supporting biomarkers such as IDH2, NEUROD1, and EZH2, and highlighting heterogeneity. However, there is very limited functional validation (only one study) and limited AI/ML usage (two studies), despite their potential to assist with small cohorts and multimodal integration.

Conclusion: This review consolidates current evidence on candidate biomarkers and therapeutic targets for ONB, highlighting the vital role of omics-based approaches in elucidating its molecular mechanisms. To advance the field, future research should focus on standardizing methods, validating findings in larger, more diverse groups, and integrating multi-omics techniques with AI–driven analyses to enhance diagnostic precision and develop targeted treatments.

Supplementary Information: The online version contains supplementary material available at 10.1007/s12672-026-05299-0.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data availability

No datasets were generated or analysed during the current study.

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 28 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 6 authors, 5 keywords, 1 funder, 45 references.

Cite

This paper

Deng, N., Chen, Z., Ung, C. O. L., Lai, Y., Song, M., & Hu, H. (2026). Omics-based exploration of biomarkers and therapeutic targets in olfactory neuroblastoma. Discover oncology, 17(1), 1090. https://doi.org/10.1007/s12672-026-05299-0

BibTeX

@article{deng2026omics,
author = {Deng, Ning and Chen, Zehao and Ung, Carolina Oi Lam and Lai, Yunfeng and Song, Menghuan and Hu, Hao},
title = {{Omics-based exploration of biomarkers and therapeutic targets in olfactory neuroblastoma}},
journal = {Discover oncology},
year = {2026},
month = may,
volume = {17},
number = {1},
pages = {1090},
publisher = {Springer},
issn = {2730-6011},
doi = {10.1007/s12672-026-05299-0},
url = {https://doi.org/10.1007/s12672-026-05299-0},
pmid = {42209957},
pmcid = {PMC13407801}
}

RIS

TY - JOUR
AU - Deng, Ning
AU - Chen, Zehao
AU - Ung, Carolina Oi Lam
AU - Lai, Yunfeng
AU - Song, Menghuan
AU - Hu, Hao
TI - Omics-based exploration of biomarkers and therapeutic targets in olfactory neuroblastoma
T2 - Discover oncology
J2 - Discov Oncol
PY - 2026
DA - 2026/05/28
VL - 17
IS - 1
SP - 1090
SN - 2730-6011
PB - Springer
DO - 10.1007/s12672-026-05299-0
UR - https://doi.org/10.1007/s12672-026-05299-0
LA - en
ER -

CSL-JSON

{
"id": "10.1007/s12672-026-05299-0",
"type": "article-journal",
"title": "Omics-based exploration of biomarkers and therapeutic targets in olfactory neuroblastoma",
"container-title": "Discover oncology",
"author": [
{
"family": "Deng",
"given": "Ning"
},
{
"family": "Chen",
"given": "Zehao"
},
{
"family": "Ung",
"given": "Carolina Oi Lam"
},
{
"family": "Lai",
"given": "Yunfeng"
},
{
"family": "Song",
"given": "Menghuan"
},
{
"family": "Hu",
"given": "Hao"
}
],
"container-title-short": "Discov Oncol",
"volume": "17",
"issue": "1",
"page": "1090",
"DOI": "10.1007/s12672-026-05299-0",
"PMID": "42209957",
"PMCID": "PMC13407801",
"ISSN": "2730-6011",
"publisher": "Springer",
"URL": "https://doi.org/10.1007/s12672-026-05299-0",
"language": "en",
"issued": {
"date-parts": [
[
2026,
5,
28
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1186/s13046-026-03681-y
Targeting FAM83D triggers tumor cell senescence via cGAS-STING signaling activation and reprograms TAMs to combat glioma.
Journal: Journal of experimental & clinical cancer research : CR
In common: genetics / omics, other condition, 1 reference
[2] doi:10.1111/bpa.13228 [code]
DistSNE: Distributed computing and online visualization of DNA methylation-based central nervous system tumor classification.
Journal: Brain pathology (Zurich, Switzerland)
In common: genetics / omics, other condition, 1 reference
[3] doi:10.1038/s41592-022-01412-7 [code]
A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution.
Journal: Nature methods
In common: genetics / omics, 1 reference
[4] doi:10.1515/med-2026-1479
A novel prognostic model based on Golgi apparatus-related genes predicts patient survival in glioblastoma.
Journal: Open medicine (Warsaw, Poland)
In common: other condition, 1 reference
[5] doi:10.1038/s41598-022-24306-2
Identification of potentially functional modules and diagnostic genes related to amyotrophic lateral sclerosis based on the WGCNA and LASSO algorithms.
Journal: Scientific reports
In common: other condition, 1 reference
[6] doi:10.1186/s12984-026-01991-y
Multimodal colour modulation for cognitive enhancement in intelligent rehabilitation: a systematic review and translational guidance.
Journal: Journal of neuroengineering and rehabilitation
In common: clinical / translational, 1 reference
[7] doi:10.1007/s00401-021-02386-0 [code]
DNA methylation-based classification of malformations of cortical development in the human brain.
Journal: Acta neuropathologica
In common: genetics / omics, 1 reference
[8] doi:10.7759/cureus.105487 [code]
A Systematic Review of Native Languages Mapped With Direct Electrical Stimulation During Awake Craniotomy.
Journal: Cureus
In common: other condition, 1 reference
[9] doi:10.1212/wnl.0000000000218031
Acute Kidney Injury and Risk of Adverse Neurocognitive Outcomes: A Systematic Review and Meta-Analysis.
Journal: Neurology
In common: clinical / translational, other condition, 1 reference
[10] doi:10.1016/j.nicl.2026.103950 [code]
Structural brain alterations in anorexia nervosa: a global brain volume and anatomical likelihood estimation (ALE) meta-analysis combined with a functional decoding approach.
Journal: NeuroImage. Clinical
In common: clinical / translational, other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.